Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Pharma
In battle with GSK's Nucala, AZ's Fasenra wins FDA nod for EGPA
The FDA has signed off on AstraZeneca's Fasenra to treat eosinophilic granulomatosis with polyangiitis, a rare, immune-mediated vascular disorder.
Kevin Dunleavy
Sep 18, 2024 11:46am
GSK touts co-administration data for RSV, shingles vaccines
Sep 18, 2024 11:22am
Lupus landscape 'poised for evolution'
Sep 17, 2024 9:55am
GSK makes Brooke Shields the star of shingles vaccination push
Sep 17, 2024 5:45am
ESMO: GSK's Zejula, pharma&'s Rubraca-Opdivo combo disappoint
Sep 14, 2024 8:45am
Meet the winners of the 2024 Fierce Pharma Marketing Awards
Sep 12, 2024 9:00am
